April Pride podcast

137. Is MDMA safe after age 70?

11/3/2026
0:00
27:02
Rewind 15 seconds
Fast Forward 15 seconds

A psychotherapist and his wife discuss 25 years of using MDMA together, testing it safely in today's drug supply, and what it taught them about grief.


šŸ”µ Episode Summary

Is MDMA safe after 70? Charley and Shelley Wininger have used it together more than a hundred times over twenty-five years, and they joined me to make the case that it belongs to midlife and beyond at least as much as it belongs to a festival crowd in their twenties.

Charley is a licensed psychoanalyst and mental health counselor in Brooklyn, practicing since 1989, and the author of "Listening to Ecstasy: The Transformative Power of MDMA." Shelley is a retired critical care nurse. Neither of them treats this casually. We get into how they source and test MDMA, including a newer complication in drug checking that most listeners haven't heard of yet, and why the medications most people over sixty five are already taking change the entire experience and need a doctor in the conversation.

We also talk about what it's actually done for their marriage, a chapter Charley reads aloud from his book about mortality, and what happened when Shelley used MDMA with a group of forty people in a park nine days after her son died.

We are living through what public health researchers call an epidemic of isolation, and the Winingers' argument is a simple one: the antidote they found was not a program. It was each other, said plainly, a few times a year, for twenty five years.


šŸ”µ Key Takeaways

  • Testing isn't one step anymore; it's two, maybe three. A reagent kit confirms MDMA is present. A fentanyl test strip checks separately for fentanyl. A newer class of synthetic opioid, chemically different from fentanyl and in some cases far more potent, won't show up on a fentanyl strip at all.
  • Roughly one in five women in their forties and fifties are on an antidepressant, and that share keeps climbing after sixty (CDC/NCHS, 2015–2018). These medications don't clear quickly, and timing MDMA around them is a conversation for a prescriber, not a solo decision.
  • A serotonin-recovery practice some people use after MDMA carries a real risk of serotonin syndrome if timed too close to the dose itself; harm reduction guidance calls for a minimum 24- to 48-hour wait.
  • Grief, not a diagnosis, is often what actually brings people to this medicine. Shelley's story is offered as one data point on that, not a treatment claim.
  • A twenty-five-year, 200-person community built on sober potluck dinners is the throughline of the Winingers' argument that MDMA's real value for this age group is connection, not escape.

šŸ”µ Timestamps

0:00 Welcome and tonight's topic: MDMA after 70

0:00 Charley and Shelley's origin story, and the "useless medicine" years

2:00 The isolation epidemic and sourcing MDMA through community

3:00 Testing MDMA safely: what's changed in the drug supply

4:00 Why Shelley tried MDMA, and what it gave her that nothing else had

5:00 Charley reads "Senior High" from his book, and the mortality conversation

7:30 Medications, contraindications, and talking to your doctor first

14:00 Community, chosen family, and 25 years of potlucks

15:30 Shelley's story: a grief circle in the park, nine days after loss

19:00 The closing question every couple should bring into the room


šŸ”µ Guest

Charley Wininger is a licensed psychoanalyst and mental health counselor based in Brooklyn, in practice since 1989, and the author of "Listening to Ecstasy: The Transformative Power of MDMA" (Park Street Press). Shelley Wininger is a retired critical care nurse. Together they've used MDMA more than a hundred times over twenty-five years. Follow Charley on Substack.


Psychedelic Salon at Town Hall Seattle: 2026-27 Schedule

Follow April on Substack

Visit aprilpride.com

Original Substack post


Hosted by April Pride

IG: @aprilpridecreates - https://instagram.com/aprilpridecreates

YouTube: https://youtube.com/@aprilpridecreates

More episodes from "April Pride"